- Home
- NRC vs MRVI Comparison
NRC vs MRVI Comparison
Compare NRC & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- MRVI
- Stock Information
- Founded
- NRC 1981
- MRVI 2014
- Country
- NRC United States
- MRVI United States
- Employees
- NRC N/A
- MRVI N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- NRC Health Care
- MRVI Health Care
- Exchange
- NRC Nasdaq
- MRVI Nasdaq
- Market Cap
- NRC 354.5M
- MRVI 371.8M
- IPO Year
- NRC N/A
- MRVI 2020
- Fundamental
- Price
- NRC $14.65
- MRVI $2.42
- Analyst Decision
- NRC
- MRVI Hold
- Analyst Count
- NRC 0
- MRVI 10
- Target Price
- NRC N/A
- MRVI $5.84
- AVG Volume (30 Days)
- NRC 101.8K
- MRVI 1.5M
- Earning Date
- NRC 10-24-2025
- MRVI 08-11-2025
- Dividend Yield
- NRC 3.27%
- MRVI N/A
- EPS Growth
- NRC N/A
- MRVI N/A
- EPS
- NRC 0.77
- MRVI N/A
- Revenue
- NRC $140,314,000.00
- MRVI $219,830,000.00
- Revenue This Year
- NRC N/A
- MRVI N/A
- Revenue Next Year
- NRC N/A
- MRVI $7.23
- P/E Ratio
- NRC $19.08
- MRVI N/A
- Revenue Growth
- NRC N/A
- MRVI N/A
- 52 Week Low
- NRC $9.76
- MRVI $1.67
- 52 Week High
- NRC $22.99
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- NRC 47.80
- MRVI 49.60
- Support Level
- NRC $14.45
- MRVI $2.28
- Resistance Level
- NRC $15.60
- MRVI $2.47
- Average True Range (ATR)
- NRC 0.64
- MRVI 0.14
- MACD
- NRC -0.03
- MRVI -0.01
- Stochastic Oscillator
- NRC 17.05
- MRVI 27.45
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.